Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Revolution Medicines is seeking a Director, US Strategic Pricing to lead the net and list price analysis and recommendations for in-line and pipeline strategies and tactics with primary internal stakeholders to maximize brand and portfolio corporate value. The Director, US Strategic Pricing will serve as a subject matter expert in US Market Access and Oncology price strategy with deep knowledge of mandated and commercial payer environments, US pricing policy and government and global pricing interdependences, and gross to net inputs and analytics. The Director will report to the Senior Director, US Strategic Pricing and will serve in a critical function to shape pricing strategy and net price life cycle management as the company transitions into a commercial organization. This role can be based from RevMed’s Redwood City, CA location or can be remotely based with up to 15% travel.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Bachelor's degree